SpringWorks Therapeutics, Inc. (SWTX)

NASDAQ: SWTX · Real-Time Price · USD

46.24

+0.06 (0.13%)

At close: Apr 29, 2025, 4:00 PM

46.17

-0.07 (-0.15%)

Pre-market: Apr 30, 2025, 8:46 AM EDT

SpringWorks Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Operating Revenue	172.04	5.45	-	-	35	Upgrade
Other Revenue	19.55	-	-	-	-	Upgrade
Revenue	191.59	5.45	-	-	35	Upgrade
Revenue Growth (YoY)	3417.33%	-	-	-	-	Upgrade
Cost of Revenue	12.55	0.42	-	-	-	Upgrade
Gross Profit	179.04	5.03	-	-	35	Upgrade
Selling, General & Admin	256.65	197.55	134.55	71.79	29.47	Upgrade
Research & Development	200.52	150.49	146.12	101.68	51.86	Upgrade
Operating Expenses	457.17	348.04	280.67	173.47	81.32	Upgrade
Operating Income	-278.13	-343.01	-280.67	-173.47	-46.32	Upgrade
Interest & Investment Income	26	22.95	6.15	0.55	1.33	Upgrade
Earnings From Equity Investments	-6	-5.04	-2.89	-0.99	-0.61	Upgrade
Other Non Operating Income (Expenses)	-	-	-	-	0.03	Upgrade
Pretax Income	-258.13	-325.1	-277.42	-173.91	-45.57	Upgrade
Net Income	-258.13	-325.1	-277.42	-173.91	-45.57	Upgrade
Net Income to Common	-258.13	-325.1	-277.42	-173.91	-45.57	Upgrade
Shares Outstanding (Basic)	74	63	53	48	43	Upgrade
Shares Outstanding (Diluted)	74	63	53	48	43	Upgrade
Shares Change (YoY)	17.44%	18.45%	9.88%	12.00%	226.18%	Upgrade
EPS (Basic)	-3.48	-5.15	-5.21	-3.59	-1.05	Upgrade
EPS (Diluted)	-3.48	-5.15	-5.21	-3.59	-1.05	Upgrade
Free Cash Flow	-180.05	-230.18	-171.76	-129.89	-32.83	Upgrade
Free Cash Flow Per Share	-2.43	-3.65	-3.22	-2.68	-0.76	Upgrade
Gross Margin	93.45%	92.25%	-	-	100.00%	Upgrade
Operating Margin	-145.17%	-6297.28%	-	-	-132.35%	Upgrade
Profit Margin	-134.73%	-5968.50%	-	-	-130.21%	Upgrade
Free Cash Flow Margin	-93.98%	-4225.81%	-	-	-93.81%	Upgrade
EBITDA	-274.66	-341.35	-279.91	-172.98	-45.98	Upgrade
EBITDA Margin	-143.36%	-	-	-	-131.36%	Upgrade
D&A For EBITDA	3.47	1.67	0.77	0.49	0.35	Upgrade
EBIT	-278.13	-343.01	-280.67	-173.47	-46.32	Upgrade
EBIT Margin	-145.17%	-	-	-	-132.35%	Upgrade
Revenue as Reported	191.59	5.45	-	-	-	Upgrade

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q